Capsules have been the standard format for dietary supplements for decades. They are inexpensive, shelf-stable and easy to take. But the more complex the formulation, the more clearly the limits of this dosage form come into view. Combining several active ingredients in a single capsule means working against the physiology of the digestive tract rather than with it.
What a Capsule Does Mechanically
Under standard conditions, a hard HPMC or gelatin capsule disintegrates within roughly five to fifteen minutes. In that brief window it releases its entire contents, at a single point in the digestive tract and in one burst. The powder, oil or granulate then disperses in the immediate vicinity of the place where it dissolved.
This works well for individual, easily absorbed substances. For a formulation with ten or more active ingredients, each of which needs different conditions for uptake, it is a systematic problem.
The Bolus Problem
For each micronutrient, the gut has specific transporters, and their number is limited. These transporters can become saturated. Studies on zinc uptake show a clear relationship: the higher the dose per intake, the smaller the percentage that is actually absorbed. With consistently high doses, the body also down-regulates the transporters further.
The same principle applies to iron, magnesium and other minerals. A capsule that releases everything at once in a single spot creates a local concentration spike that overwhelms precisely the mechanisms responsible for uptake. Most of the active ingredients pass through the gut unused.
Where Active Ingredients Are Actually Absorbed
The three sections of the small intestine each have their own absorption specialisations. The duodenum mainly absorbs iron, calcium, magnesium, copper, selenium and a portion of the fat-soluble vitamins. The jejunum is the principal site of uptake for most water-soluble vitamins, zinc and amino acids. In the ileum, vitamin B12, bile acids, part of the vitamin D and K, as well as additional magnesium are absorbed.
A single capsule that opens in the upper small intestine no longer reaches the ileum in any meaningful concentration. Substances that belong there are released prematurely in regions where the matching transporters are absent.
Acid-Resistant Capsules: Half a Step
Delayed-release capsules, for example those made from specially formulated HPMC, solve one concrete problem: they survive stomach acid and open only in the more neutral environment of the small intestine. This protects sensitive active ingredients such as probiotic and postbiotic cultures, enzymes or oxidation-sensitive fatty acids from being destroyed.
What these capsules do not do:
- They do not distribute release across several intestinal sections. An acid-resistant capsule, too, opens at a single point, simply further down.
- They control the rate of release only roughly. Typical release happens within about thirty minutes, not in several precisely timed phases.
- They do not replace lipid carriers. Fat-soluble active ingredients need bile and an emulsified lipid environment in order to be taken up into micelles. A dry powder in an acid-resistant shell does not meet that requirement.
- They do not change the form of the active ingredient. Omega-3 as an ethyl ester is absorbed less well than the free fatty acid or the natural triglyceride, regardless of the type of capsule.
Acid resistance solves the question of survival, not the question of uptake.
Synergies Need Closeness in Space and Time
Micronutrients rarely act in isolation. Three examples make this concrete:
Vitamin D3 without magnesium stays inactive. Both the conversion of D3 to 25(OH)D in the liver and its activation to calcitriol in the kidney require magnesium as a cofactor of the enzymes involved. Taking high-dose D3 without an adequate magnesium supply additionally draws on the body's own magnesium reserves, without delivering the full benefit of the vitamin.
Vitamin D3 without K2 does not transport calcium to the right place. D3 contributes to normal absorption and utilisation of calcium. K2 activates the protein osteocalcin, which incorporates calcium into bone. Without this time-coupled availability of both vitamins, the absorbed calcium remains functionally less well directed.
Fat-soluble vitamins without a lipid carrier are excreted. Vitamins A, D, E and K can only be taken up into the intestinal mucosa when they form micelles together with bile salts. Without a lipid environment they stay trapped in undigested material and leave the body unused.
In all three cases, what matters is not only that the active ingredients are present. They have to be in the same place, at the same time and in the right physical state.
What a Modern Multi-Ingredient Formulation Has to Deliver
Physiology gives rise to several requirements that a standard capsule, by its nature, cannot meet:
-
A lipid-based carrier for fat-soluble active ingredients. An oil suspension or emulsion already supplies the vitamins in the state in which they need to be absorbed. Studies on omega-3 uptake show that emulsified forms are more bioavailable than classic softgels.
-
Spatially distributed release. Multiphase systems, for example sachets with differently coated microparticles, enable staggered release across several intestinal sections.
-
Avoiding concentration spikes. A formulation that releases an active ingredient over time keeps the local concentration below the saturation threshold of the transporters. This increases the percentage that is actually absorbed.
-
Protecting sensitive active ingredients without losing bioavailability. Probiotics and postbiotics, omega-3 in triglyceride form and certain vitamins have to survive stomach acid without the dosage form hindering uptake at a later point.
-
Synergistic co-availability. Cofactors such as magnesium for vitamin D activation or K2 for calcium transport have to be provided together with their partners, in amounts that actually support the respective chain of action.
Conclusion
A standard capsule is an elegant solution for a simple task. For complex micronutrient formulations, in which several substances are meant to act in coordination, it runs into structural limits. Acid-resistant variants move the problem into the small intestine but do not solve it. Anyone who wants to actually absorb the active ingredients of a modern formulation needs a dosage form that follows digestive physiology: staggered, lipid-compatible and matched to the synergies of the ingredients.
VYKEA OMNIA relies on a sachet formulation with an oil suspension and SphiroX encapsulation. This makes it possible to provide fat-soluble vitamins, minerals and omega-3 in a form that works with absorption in the gut rather than against it.
Health claims in accordance with Regulation (EU) No 432/2012.
